… personalized approach to the monitoring of patients with ATTRv amyloidosis is needed,
with … to inform management decisions. No validated approach to such monitoring has been …

… Stratification of patients with ATTR-CM is critical for optimal management and treatment;
however, monitoring disease progression is challenging and currently lacks best-practice …

… ATTR amyloidosis … monitoring disease state and detecting disease progression based on
a literature review of expert opinion articles and management guidelines on ATTRv amyloidosis…

… Systemic monitoring of asymptomatic carriers should be considered at least 10 years prior
… For patients with systemic ATTR amyloidosis, TTR amyloid detection and characterisation in …

… Management of ATTR-CA involves providing appropriate HF … amyloid patients is largely
dependent on careful monitoring … entirely or closely monitored for symptomatic hypotension if …

… light chain amyloidosis (AL) caused by monoclonal immunoglobulin light chains and
transthyretin amyloidosis (ATTR) caused by either mutated or wild-type transthyretin aggregates. …

… We discussed recommendations on monitoring of early signs of ATTRv amyloidosis. …
predictive genetic testing and management of pathogenic TTR gene mutation carriers [4,13]. …

… transthyretin amyloidosis gene mutation carriers for cardiac involvement, and the ideal method
for monitoring … recent advances in treatment for transthyretin amyloidosis‐CA, including a …

… systems in TTR amyloidosis should also be considered. Nevertheless, monitoring response
… In conclusion Tafamidis is a safe drug easy to manage, for patients and doctors. It is the only …

… amyloidosis, such as TTR stabilizers, short interfering RNA (siRNA), and antisense
oligonucleotides (ASOs), early diagnosis and better management … management of ATTR …